Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB02659
http://purl.obolibrary.org/obo/dinto_DB02659
|
|---|---|
| Preferred Name | cholic acid |
| Synonyms |
C24H40O5
(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | cholic acid
|
|---|---|
| label | cholic acid
|
| ATCCode | A05AA03
|
| Definition | A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. [PubChem]
|
| induces |
See more
See less
|
| inhibits |
See more
See less
|
| type | |
| InChIKey | InChIKey=BHQCQFFYRZLCQQ-OELDTZBJSA-N
|
| Synonym | C24H40O5
(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid
|
| xref |
PDB:CHD
ChemSpider:192176
PubChem Compound:221493
PubChem Substance:46507063
ChEBI:16359
BindingDB:21680
See more
See less
|
| CASRN | 81-25-4
|
| prefixIRI | obo2:dinto_DB02659
|
| is transported by | |
| related with |
See more
See less
|
| SMILES | [H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
|
| InChI | InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |